HER2 quantification by mass spectrometry compared to IHC or ISH in predicting clinical benefit from anti-HER2 therapy in HER2-positive breast cancer (BC) Meeting Abstract
| Authors: | Nuciforo, P.; Aura, C.; Thyparambil, S. P.; Vilaro, M.; Garrido-Castro, A. C.; Peg, V.; Jimenez, J.; Hoos, W. A.; Burrows, J.; Hembrough, T. A.; Perez-Garcia, J. M.; Cortes, J.; Scaltriti, M. |
| Abstract Title: | HER2 quantification by mass spectrometry compared to IHC or ISH in predicting clinical benefit from anti-HER2 therapy in HER2-positive breast cancer (BC) |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901365 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.605 |
| Notes: | Meeting Abstract: 605 -- Source: Wos |
